WEBINAR ON DEMAND
Duration: 1 hour

Cellular and gene therapies are expected to represent one of the greatest advances in medical treatments since the introduction of monoclonal antibodies.

Cellular therapies are having a significant impact on hematological malignancies, while gene therapy programs for rare and non-rare diseases could benefit some 2.4 billion patients worldwide.

Researchers anticipate an increase of gene therapy products that can address monogenic inherited diseases, such as those that involve metabolic disorder and neurological conditions – it’s an enormous opportunity.

This webinar addresses the complex path to developing and commercializing a cell and gene therapy product, common obstacles, strategies for patient recruitment and more. At the end of the webinar, participants will be able to:

• Understand clinical potential for cell and gene therapies
• Take steps to avoid barriers for trial delivery
• Implement effective strategy for patient recruitment inclusive of pediatric populations
• Structure protocols for minimal patient burden and maximal study procedure compliance

SPEAKERS  

Matthew Cooney, M.D.
Vice President, Global Medical Services
Parexel

Roberta Steere
Senior Solutions Consultant Director, Early Product Development, Oncology
Parexel

Altair Silva
Director – Integrated Solutions Patient Recruitment Strategy Group
Parexel